Menu

Image of the Day: Performance Anxiety

In the presence of competition, archerfish become more hesitant but accurate shooters.

Jun 21, 2018
Sukanya Charuchandra

ABOVE: An archerfish takes aim. 

While targeting prey with a stream of water, archerfish become reluctant when being watched by other fish. Known for their ability to aim before spraying their victim, archerfish will shift their position several times before lining up their shots. In research published in Animal Behavior on June 15, researchers suggest this social anxiety–induced behavior may help archerfish beat out their competition by increasing their accuracy.

“Archerfish may be famous for their shooting ability, but they may be even more remarkable for their capacity for making rapid decisions with high accuracy,” study coauthor Nick Jones, a doctoral student at the University of St. Andrews in the U.K., says in a statement.

N.A.R. Jones et al., “Presence of an audience and consistent interindividual differences affect archerfish shooting behaviour,” Anim Behav, doi:10.1016/j.anbehav.2018.04.024, 2018.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!